Edition:
United States

Biosynex SA (ALBIO.PA)

ALBIO.PA on Paris Stock Exchange

3.91EUR
11:17am EDT
Change (% chg)

€0.10 (+2.62%)
Prev Close
€3.81
Open
€4.00
Day's High
€4.03
Day's Low
€3.90
Volume
18,915
Avg. Vol
7,008
52-wk High
€5.44
52-wk Low
€2.14

ALBIO.PA

Chart for ALBIO.PA

About

Biosynex SA is a France-based company that specializes in the research, development and manufacture of in-vitro diagnostic kits aimed at health professionals. The Company’s products are used by biological and analytical services laboratories, obstetric units and emergency units, as well as in medical resource-limited settings.... (more)
No analyst recommendations are available for ALBIO.PA.

Overall

Beta: 1.34
Market Cap(Mil.): €32.64
Shares Outstanding(Mil.): 8.57
Dividend: --
Yield (%): --

Financials

  ALBIO.PA Industry Sector
P/E (TTM): -- 32.06 15.73
EPS (TTM): -0.15 -- --
ROI: -4.04 13.43 -8.37
ROE: -4.25 15.87 -7.93

BRIEF-Biosynex announces private placement of 2 million euros

* ANNOUNCES PRIVET PLACEMENT OF OF EUR 2 MILLION IN NEW SHARES Source text for Eikon: Further company coverage: (Gdynia Newsroom)

12:28pm EDT

BRIEF-Biosynex H1 revenue up at 15.6 million euros

* H1 REVENUE EUR 15.6 MILLION VERSUS EUR 13.3 MILLION YEAR AGO

Jul 24 2017

BRIEF-Biosynex raises 1.96 million euros in capital increase

* PLACEMENT OVERSUBSRCRIBED BY 213% Source text: http://bit.ly/2ug41VT Further company coverage: (Gdynia Newsroom)

Jul 21 2017

BRIEF-Biosynex launches capital increase for a maximum amount of 1.96 million euros

* LAUNCHES CAPITAL INCREASE GUARANTEED BY FOUNDING SHAREHOLDERS WITH PREFERENTIAL SUBSCRIPTION RIGHTS FOR MAXIMUM AMOUNT OF € 1.96 MILLION

Jul 03 2017

BRIEF-Biosynex acquires company SR2B

* ACQUISITION EXPECTED TO COMPLETE ON JULY 3, 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Jun 07 2017

BRIEF-Biosynex FY operating profit up at 0.8 million euros

* FY operating profit of 0.8 million euros ($870,000.00) versus loss of 0.3 million euros year ago

Apr 27 2017

BRIEF-Biosynex FY 2016 revenue rises to 27.0 million euros

* FY 2016 revenue 27.0 million euros ($29.01 million) versus 20.1 million euros a year ago Source text for Eikon: Further company coverage: ($1 = 0.9308 euros) (Gdynia Newsroom)

Jan 26 2017

Earnings vs. Estimates